A comparative study between efficacy of Methotrexate monotherapy and Methotrexate-Metformin combination therapy in reducing the hsCRP in moderate to severe psoriasis patients - NI

Saveetha Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年11月13日

试验速览

暂无简介。

•1. Patients with both psoriasis vulgaris and metabolic syndrome between the ages of 18 and 70 years consenting to be a part of the study
•2. Patients with chronic plaque psoriasis
•3. Patients with active disease
•4. Patients who are currently not on any systemic treatment
•5. Patients are nonalcoholic; liver and kidney function tests are normal

•1. Patients not willing to be a part of the study
•2. Patients not consenting for biopsy or blood test
•3. Patients diagnosed with conditions other than psoriasis
•4. Patient is pregnant or lactating
•5. Patient has been using systemic drugs to treat psoriasis—such as cyclosporine, retinoid, or immunologic therapy—for one month or more
•6. Patient has acute or chronic infection
•7. Contraindication to use metformin and methotrexate

发起方

Saveetha Medical College